The DEI Mandate: What's on the Horizon and What's Needed for IRB and Recruitment Processes

Are you prepared to meet the Food and Drug Administration's (FDA) upcoming requirements on Diversity Action Plans for clinical trials? Learn what the new guidance outlines, including the format, content, timing, and process of implementing Diversity Action Plans into clinical trials. Incorporating comprehensive Diversity, Equity, and Inclusion (DEI) strategies into trial planning, design, and execution enhances representation, optimizes health equity, and strengthens site selection, recruitment, and ethical review.